A fatty diet during pregnancy in mouse dams causes metabolic abnormalities (similar to metabolic syndrome in humans) in the rodents’ offspring. We tested the hypothesis that the offspring of dams fed a high-fat diet during pregnancy and lactation develop metabolic abnormalities and leptin resistance. Pregnant C57BL/6 mice (n = 20) were fed either standard chow (SC; 19% fat) or a high-fat diet (HF; 49% fat). After weaning, male offspring were divided into four groups, according to the diet of dams and offspring: SC(dams)/SC(offspring), SC/HF, HF/SC and HF/HF (n = 30/group). For a metabolic analysis, we evaluated body mass, fat mass depots, blood plasma and adipocyte structure at 12 weeks of age. To analyse leptin sensitivity, each group was divided into two groups (vehicle or leptin) to identify the feeding response and pSTAT3 expression after acute intracerebroventricular (ICV) treatment. The offspring of mothers fed a high-fat diet presented increased body mass and visceral fat, adipocyte hypertrophy and insulin resistance. This phenotype was not associated with central leptin resistance. Thus, maternal programming by HF predisposes offspring to metabolic abnormalities despite leptin sensitivity.

1.
Barker DJ: In utero programming of chronic disease. Clin Sci (Lond) 1998; 95:115–128.
2.
Langley-Evans SC, McMullen S: Developmental origins of adult disease. Med Princ Pract 2010;19:87–98.
3.
Armitage JA, et al: Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals? J Physiol 2004;561(Pt 2):355–377.
4.
Waterland RA, Jirtle RL: Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004;20:63–68.
5.
Parente LB, Aguila MB, Mandarim-de-Lacerda CA: Deleterious effects of high-fat diet on perinatal and postweaning periods in adult rat offspring. Clin Nutr 2008;27:623–634.
6.
Gregorio BM, et al: Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL/6 offspring. Am J Obstet Gynecol 2010;203:495e1–8.
7.
Guo F, Jen KL: High-fat feeding during pregnancy and lactation affects offspring metabolism in rats. Physiol Behav 1995;57:681–686.
8.
Collins S, et al: Role of leptin in fat regulation. Nature 1996;380:677.
9.
Ferezou-Viala J, et al: Long-term consequences of maternal high-fat feeding on hypothalamic leptin sensitivity and diet-induced obesity in the offspring. Am J Physiol Regul Integr Comp Physiol 2007;293:R1056–R1062.
10.
Beck B, et al: Hypothalamic orexigenic peptides are overexpressed in young Long-Evans rats after early life exposure to fat-rich diets. Biochem Biophys Res Commun 2006;342:452–458.
11.
Bouret SG: Early life origins of obesity: role of hypothalamic programming. J Pediatr Gastroenterol Nutr 2009;48(suppl 1):S31–S38.
12.
Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998;395:763–770.
13.
Hubschle T, et al: Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci 2001;21:2413–2324.
14.
Gao Q, et al: Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 2004;101:4661–4666.
15.
Hofbauer KG: Molecular pathways to obesity. Int J Obes Relat Metab Disord 2002;26(suppl 2):S18–S27.
16.
Hamann A, Matthaei S: Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 1996;104:293–300.
17.
Fraulob JC, et al: A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46:212–223.
18.
Reeves PG, Nielsen FH, Fahey GC, Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939–1951.
19.
Matthews DR, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
20.
Mandarim-de-Lacerda CA: Stereological tools in biomedical research. An Acad Bras Cienc 2003;75:469–486.
21.
Catta-Preta M, et al: Modulation of cytokines, resistin, and distribution of adipose tissue in C57BL/6 mice by different high-fat diets. Nutrition 2012;28:212–219.
22.
Prieur X, et al: Leptin regulates peripheral lipid metabolism primarily through central effects on food intake. Endocrinology 2008;149:5432–5439.
23.
Harris RB, Bowen HM, Mitchell TD: Leptin resistance in mice is determined by gender and duration of exposure to high-fat diet. Physiol Behav 2003;78:543–555.
24.
Morrison CD, et al: Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology 2007;148:433–440.
25.
Seo S, et al: Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet 2009;18:1323–1331.
26.
Plagemann A: Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav 2005;86:661–668.
27.
Gluckman PD, Hanson MA: Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 2004;56:311–317.
28.
Taylor PD, et al: Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy. Am J Physiol Regul Integr Comp Physiol 2005;288:R134–R139.
29.
Winzell MS, Ahren B: The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004;53(suppl 3):S215–S219.
30.
Taylor SI, Accili D, Imai Y: Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 1994;43:735–740.
31.
Cerf ME: High fat programming of beta-cell failure. Adv Exp Med Biol 2010;654:77–89.
32.
Cerf ME, et al: Islet cell response in the neonatal rat after exposure to a high-fat diet during pregnancy. Am J Physiol Regul Integr Comp Physiol 2005;288: R1122–R1128.
33.
Gniuli D, et al: Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny. J Lipid Res 2008;49:1936–1945.
34.
Neuschwander-Tetri BA: Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci 2005;330:326–335.
35.
Gauthier MS, Favier R, Lavoie JM: Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr 2006;95:273–281.
36.
Charney E, et al: Childhood antecedents of adult obesity. Do chubby infants become obese adults? N Engl J Med 1976;295:6–9.
37.
Koteish A, Diehl AM: Animal models of steatosis. Semin Liver Dis 2001;21:89–104.
38.
den Boer M, et al: Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol 2004;24:644–649.
39.
McCurdy CE, et al: Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009;119:323–335.
40.
Hartil K, et al: Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in utero. Pediatr Res 2009;66:368–373.
41.
Jones HN, et al: High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J 2009;23:271–278.
42.
Spiegelman BM, Flier JS: Obesity and the regulation of energy balance. Cell 2001;104:531–543.
43.
Conceicao EP, et al: Higher white adipocyte area and lower leptin production in adult rats overfed during lactation. Horm Metab Res 2011;43:513–516.
44.
Frederich RC, et al: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995;1:1311–1314.
45.
Teegarden SL, Scott AN, Bale TL: Early life exposure to a high fat diet promotes long-term changes in dietary preferences and central reward signaling. Neuroscience 2009;162:924–932.
46.
Gupta A, et al: Hypothalamic alterations in fetuses of high fat diet-fed obese female rats. J Endocrinol 2009;200:293–300.
47.
Plum L, Schubert M, Bruning JC: The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 2005;16:59–65.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.